Basit öğe kaydını göster

Prognostic significance of asxl1, JAK2V617F mutations and JAK2V617F allele burden in philadelphia-negative myeloproliferative neoplasms

dc.contributor.authorYavuz, Akif Selim
dc.contributor.authorDaglar-Aday, Aynur
dc.contributor.authorYILMAZ, Ceylan
dc.contributor.authorNALÇACI, Meliha
dc.contributor.authorYONAL-HINDILERDEN, Ipek
dc.contributor.authorSARGIN, Deniz
dc.contributor.authorAKADAM-TEKER, Basak
dc.date.accessioned2021-03-05T19:31:36Z
dc.date.available2021-03-05T19:31:36Z
dc.identifier.citationYONAL-HINDILERDEN I., Daglar-Aday A., AKADAM-TEKER B., YILMAZ C., NALÇACI M., Yavuz A. S. , SARGIN D., "Prognostic significance of asxl1, JAK2V617F mutations and JAK2V617F allele burden in philadelphia-negative myeloproliferative neoplasms", Journal of Blood Medicine, cilt.6, ss.157-175, 2015
dc.identifier.othervv_1032021
dc.identifier.otherav_cfb41511-3805-4dc3-aec6-b3760d8a4976
dc.identifier.urihttp://hdl.handle.net/20.500.12627/137331
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84939121216&origin=inward
dc.identifier.urihttps://doi.org/10.2147/jbm.s78826
dc.language.isoeng
dc.titlePrognostic significance of asxl1, JAK2V617F mutations and JAK2V617F allele burden in philadelphia-negative myeloproliferative neoplasms
dc.typeMakale
dc.relation.journalJournal of Blood Medicine
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume6
dc.identifier.startpage157
dc.identifier.endpage175
dc.contributor.firstauthorID112655


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster